SOURCE: World Street Fundamentals

May 17, 2011 09:00 ET

Health Care Reform & Industry Outlook - Equity Research on Orthovita, Inc. and Johnson & Johnson

HONG KONG--(Marketwire - May 17, 2011) - Today, www.WorldStreetFundamentals.com released its industry report highlighting Orthovita, Inc. (NASDAQ: VITA) and Johnson & Johnson (NYSE: JNJ). Full fundamental and technical analysis is available at www.WorldStreetFundamentals.com/Reports.php.

Preliminary thoughts from industry analysts expect recent health care reform legislation to negatively affect industry profitability over the next few years, offset by eventual benefits accruing from significant expansion of the market, with new coverage potentially being provided to 31.9 million currently uninsured Americans. With this in mind, investors are favoring shares of firms with well-defined growth prospects and generous dividend yields, as general consensus expects relatively good performance of such equities over the coming quarters.

The pharmaceutical industry remains one of the widest-margin U.S. industries, with prospects enhanced by demographic growth in the elderly and new drugs stemming from discoveries in genomics and biotechnology. As such, long term fundamentals remain favorable as additional longer-range benefits from cost restructurings and merger synergies are anticipated.

World Street Fundamentals has highlighted Orthovita for its focus as a specialty spine and orthopedic company with a portfolio of orthobiologic and biosurgery products. Its orthobiologic platform includes products for the fusion, regeneration and fixation of human bone. Its orthobiologic products are based on its Vitoss Bone Graft Substitute technology and include the Imbibe Bone Marrow Aspiration System used with Vitoss. Its orthobiologic products also include Cortoss Bone Augmentation Material and the Aliquot Delivery System used with Cortoss. The entire report on Orthovita, Inc. (NASDAQ: VITA) is available here: www.WorldStreetFundamentals.com/ViewFullReport.245.php.

World Street has highlighted Johnson & Johnson for its engagement in the research and development, manufacture and sale of a range of products in the health care field. It has more than 250 operating companies conducting business worldwide. The Company's operating companies are organized into three business segments: Consumer, Pharmaceutical and Medical Devices and Diagnostics. The Company and its subsidiaries operate 139 manufacturing facilities occupying approximately 21.8 million square feet of floor space. The entire report on Johnson & Johnson (NYSE: JNJ) is available here: www.WorldStreetFundamentals.com/ViewFullReport.138.php.

About World Street
World Street Fundamentals is an online portal for professionals, investors and new-comers to the markets to find in depth comprehensive research and research tools to help guide you through the ever changing financial markets. Covering the top performers in the hottest sectors and providing clarity to investors around the world.

Contact Information